Wolverine Trading, LLC Tg Therapeutics, Inc. Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

A detailed history of Wolverine Trading, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 12,279 shares of TGTX stock, worth $395,383. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,279
Previous 14,762 16.82%
Holding current value
$395,383
Previous $262,000 9.54%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$17.21 - $25.28 $42,732 - $62,770
-2,483 Reduced 16.82%
12,279 $287,000
Q2 2024

Aug 14, 2024
SELL
$13.32 - $19.19 $392,646 - $565,682
-29,478 Reduced 66.63%
14,762 $262,000
Q1 2024

May 15, 2024
BUY
$13.02 - $21.3 $576,004 - $942,312
44,240 New
44,240 $672,000
Q3 2023

Nov 15, 2023
SELL
$8.36 - $26.5 $31,299 - $99,216
-3,744 Reduced 13.42%
24,155 $201,000
Q2 2023

Aug 23, 2023
BUY
$15.48 - $35.0 $431,876 - $976,465
27,899 New
27,899 $693,000
Q1 2022

May 16, 2022
SELL
$7.81 - $20.45 $78,162 - $204,663
-10,008 Reduced 42.18%
13,720 $135,000
Q4 2021

Feb 14, 2022
SELL
$15.2 - $35.51 $9,211 - $21,519
-606 Reduced 2.49%
23,728 $459,000
Q3 2021

Nov 12, 2021
SELL
$21.78 - $40.45 $124,690 - $231,576
-5,725 Reduced 19.05%
24,334 $817,000
Q2 2021

Aug 06, 2021
BUY
$32.5 - $48.96 $24,700 - $37,209
760 Added 2.59%
30,059 $1.13 Million
Q1 2021

May 14, 2021
SELL
$41.61 - $54.3 $2.37 Million - $3.09 Million
-56,930 Reduced 66.02%
29,299 $1.33 Million
Q4 2020

Feb 12, 2021
SELL
$25.27 - $54.9 $216,639 - $470,657
-8,573 Reduced 9.04%
86,229 $4.56 Million
Q3 2020

Nov 13, 2020
BUY
$18.49 - $27.24 $266,015 - $391,901
14,387 Added 17.89%
94,802 $2.48 Million
Q2 2020

Aug 13, 2020
SELL
$8.9 - $21.84 $204,726 - $502,385
-23,003 Reduced 22.24%
80,415 $1.49 Million
Q1 2020

May 11, 2020
BUY
$7.14 - $15.99 $6,725 - $15,062
942 Added 0.92%
103,418 $1.07 Million
Q4 2019

Feb 12, 2020
BUY
$5.1 - $11.2 $13,356 - $29,332
2,619 Added 2.62%
102,476 $1.11 Million
Q3 2019

Nov 14, 2019
BUY
$5.38 - $8.99 $106,330 - $177,678
19,764 Added 24.68%
99,857 $564,000
Q2 2019

Aug 20, 2019
SELL
$6.27 - $8.65 $383,774 - $529,449
-61,208 Reduced 43.32%
80,093 $693,000
Q1 2019

May 15, 2019
BUY
$4.02 - $8.04 $274,047 - $548,094
68,171 Added 93.22%
141,301 $1.14 Million
Q4 2018

Feb 14, 2019
BUY
$3.44 - $5.76 $87,014 - $145,699
25,295 Added 52.88%
73,130 $291,000
Q3 2018

Nov 14, 2018
BUY
$5.15 - $14.0 $149,396 - $406,126
29,009 Added 154.09%
47,835 $268,000
Q1 2018

May 15, 2018
BUY
$8.7 - $16.8 $163,786 - $316,276
18,826 New
18,826 $267,000

Others Institutions Holding TGTX

# of Institutions
338
Shares Held
87.7M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.68B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email